SecBot SecBot
SECBOTREPLAY Home › Report › ABT

ABT · This is a routine procedural order in a consumer class action against…

ABBOTT LABORATORIES · COURT-RULING filed Sep 13, 2026 at 20:00 ET

At the news

NEUTRALIMPACT 1/10

COURT-RULING filed Sep 13, 2026 at 20:00 ET

This is a routine procedural order in a consumer class action against Abbott Diabetes Care and Abbott Laboratories regarding FreeStyle CGM products. The parties jointly stipulated to extend the deadline to submit a proposed ESI protocol from September 14, 2026 to October 6, 2026. The order contains no substantive rulings on liability, damages, or injunctive relief, it is a scheduling extension, the fourth such request, with no impact on any other case deadlines. For a $178B market cap company, this is immaterial housekeeping.

  • Court granted a joint stipulation to extend the deadline for submitting a proposed ESI protocol from September 14, 2026 to October 6, 2026.
  • This is the fourth stipulated extension of this deadline in the FreeStyle CGM consumer litigation.
  • The order does not alter any other case deadlines or events.
  • No substantive ruling on liability, damages, or injunctive relief was made.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access